Elimination of vancomycin-resistant enterococci from a neonatal intensive care unit following an outbreak

Journal of Hospital Infection

Volumn 74, Issue 4, 2010, Pages 370-376

  Ergaz, Z ^a   Arad, I ^a   Bar Oz, B ^a   Peleg, O ^a   Benenson, S ^a   Minster, N ^a   Moses, A ^a   Block, C ^a  

^a HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

Author keywords

Bloodstream infection; Infection control; Linezolid; Meningitis; Neonatal intensive care unit; Vancomycin resistant enterococci

Indexed keywords

CEFOTAXIME; LINEZOLID; VANCOMYCIN; ANTIINFECTIVE AGENT; BACTERIAL PROTEIN; LIGASE; VANA LIGASE, BACTERIA;

ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL COLONIZATION; BACTERIAL MENINGITIS; BLOODSTREAM INFECTION; CASE REPORT; DRUG SUBSTITUTION; DRUG WITHDRAWAL; ENTEROCOCCAL INFECTION; ENTEROCOCCUS FAECIUM; EPIDEMIC; FECES CULTURE; FEMALE; HUMAN; INFANT; INFECTION CONTROL; MALE; NEWBORN INTENSIVE CARE; PULSED FIELD GEL ELECTROPHORESIS; VANCOMYCIN RESISTANT ENTEROCOCCUS; ADULT; ANTIBIOTIC RESISTANCE; BACTERIUM IDENTIFICATION; CLUSTER ANALYSIS; CROSS INFECTION; DNA FINGERPRINTING; DRUG EFFECT; FECES; GENETICS; GRAM POSITIVE INFECTION; HETEROZYGOTE; ISOLATION AND PURIFICATION; ISRAEL; METHODOLOGY; MICROBIOLOGY; NEWBORN;

ADULT; ANTI-BACTERIAL AGENTS; BACTERIAL PROTEINS; BACTERIAL TYPING TECHNIQUES; CARBON-OXYGEN LIGASES; CARRIER STATE; CLUSTER ANALYSIS; CROSS INFECTION; DISEASE OUTBREAKS; DNA FINGERPRINTING; ELECTROPHORESIS, GEL, PULSED-FIELD; ENTEROCOCCUS FAECIUM; FECES; FEMALE; GRAM-POSITIVE BACTERIAL INFECTIONS; HUMANS; INFANT, NEWBORN; INFECTION CONTROL; INTENSIVE CARE, NEONATAL; ISRAEL; MALE; VANCOMYCIN RESISTANCE; YOUNG ADULT;

EID: 77952566010     PISSN: 01956701     EISSN: 15322939     Source Type: Journal    
DOI: 10.1016/j.jhin.2009.08.017     Document Type: Article

References (28)

1. Murray B.E. Vancomycin-resistant enterococcal infections. N Engl J Med 2000, 342:710-721.
2. Sohn A.H., Garrett D.O., Sinkowitz-Cochran R.L., et al. Prevalence of nosocomial infections in neonatal intensive care unit patients: results from the first national point-prevalence survey. J Pediatr 2001, 139:821-827.
3. Toledano H., Schlesinger Y., Raveh D., et al. Prospective surveillance of vancomycin-resistant enterococci in a neonatal intensive care unit. Eur J Clin Microbiol Infect Dis 2000, 19:282-287.
4. Yuce A., Karaman M., Gulay Z., Yulug N. Vancomycin-resistant enterococci in neonates. Scand J Infect Dis 2001, 33:3-5.
5. Ergani-Ozcan A., Naas T., Baysan B.O., et al. Nosocomial outbreak of vancomycin-resistant Enterococcus faecium in a paediatric unit at a Turkish university hospital. J Antimicrob Chemother 2008, 61:1033-1039.
6. Borgmann S., Niklas D.M., Klare I., et al. Two episodes of vancomycin-resistant Enterococcus faecium outbreaks caused by two genetically different clones in a newborn intensive care unit. Int J Hyg Environ Health 2004, 207:386-389.
7. Isenberg HD (Ed.). Identification of gram positive bacteria. In: Clinical microbiology procedures handbook. 2nd edn. Washington, DC: American Society for Microbiology; 2004. 3.18.1.1-3.18.1.15 (Garcia LS, Ed.); update 2007.
8. Dutka-Malen S., Evers S., Courvalin P. Detection of glycopeptide resistance genotypes and identification to the species level of clinically relevant enterococci by PCR. J Clin Microbiol 1995, 33:24-27.
9. Tenover F.C., Arbeit R.D., Goering R.V., et al. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J Clin Microbiol 1995, 33:2233-2239.
10. Golan Y., Doron S., Sullivan B., Snydman D.R. Transmission of vancomycin-resistant enterococcus in a neonatal intensive care unit. Pediatr Infect Dis J 2005, 24:566-567.
11. Rupp M.E., Marion N., Fey P.D., et al. Outbreak of vancomycin-resistant Enterococcus faecium in a neonatal intensive care unit. Infect Control Hosp Epidemiol 2001, 22:301-303.
12. Malik R.K., Montecalvo M.A., Reale M.R., et al. Epidemiology and control of vancomycin-resistant enterococci in a regional neonatal intensive care unit. Pediatr Infect Dis J 1999, 18:352-356.
13. Khan E., Sarwari A., Hasan R., et al. Emergence of vancomycin-resistant Enterococcus faecium at a tertiary care hospital in Karachi. Pakistan. J Hosp Infect 2002, 52:292-296.
14. McNeeley D.F., Saint-Louis F., Noel G.J. Neonatal enterococcal bacteremia: an increasingly frequent event with potentially untreatable pathogens. Pediatr Infect Dis J 1996, 15:800-805.
15. Ang J.Y., Lua J.L., Turner D.R., Asmar B.I. Vancomycin-resistant Enterococcus faecium endocarditis in a premature infant successfully treated with linezolid. Pediatr Infect Dis J 2003, 22:1101-1103.
16. Lee H.K., Lee W.G., Cho S.R. Clinical and molecular biological analysis of a nosocomial outbreak of vancomycin-resistant enterococci in a neonatal intensive care unit. Acta Paediatr 1999, 88:651-654.
17. Moreno F., Grota P., Crisp C., et al. Clinical and molecular epidemiology of vancomycin-resistant Enterococcus faecium during its emergence in a city in southern Texas. Clin Infect Dis 1995, 21:1234-1237.
18. Boyce J.M., Opal S.M., Chow J.W., et al. Outbreak of multidrug-resistant Enterococcus faecium with transferable vanB class vancomycin resistance. J Clin Microbiol 1994, 32:1148-1153.
19. Torres-Viera C., Dembry L.M. Approaches to vancomycin-resistant enterococci. Curr Opin Infect Dis 2004, 17:541-547.
20. Krediet T.G., Jones M.E., Gerards L.J., Fleer A. Clinical outcome of cephalothin versus vancomycin therapy in the treatment of coagulase-negative staphylococcal septicemia in neonates: relation to methicillin resistance and mec A gene carriage of blood isolates. Pediatrics 1999, 103:E29.
21. Perez Mato S., Robinson S., Begue R.E. Vancomycin-resistant Enterococcus faecium meningitis successfully treated with chloramphenicol. Pediatr Infect Dis J 1999, 18:483-484.
22. Langgartner M., Mutenthaler A., Haiden N., Pollak A., Berger A. Linezolid for treatment of catheter-related cerebrospinal fluid infections in preterm infants. Arch Dis Child Fetal Neonatal Ed 2008, 93:F397.
23. Kumar S., Kohlhoff S., Valencia G., Hammerschlag M.R., Sharma R. Treatment of vancomycin-resistant Enterococcus faecium ventriculitis in a neonate. Int J Antimicrob Agents 2007, 29:740-741.
24. Singh N., Leger M.M., Campbell J., Short B., Campos J.M. Control of vancomycin-resistant enterococci in the neonatal intensive care unit. Infect Control Hosp Epidemiol 2005, 26:646-649.
25. Mondy K.E., Shannon W., Mundy L.M. Evaluation of zinc bacitracin capsules versus placebo for enteric eradication of vancomycin-resistant Enterococcus faecium. Clin infect dis 2001, 33:473-476.
26. Hachem R., Raad I. Failure of oral antimicrobial agents in eradicating gastrointestinal colonization with vancomycin-resistant enterococci. Infect Control Hosp Epidemiol 2002, 23:43-44.
27. Duchon J., Graham P., Della-Latta P., et al. Epidemiology of enterococci in a neonatal intensive care unit. Infect Control Hosp Epidemiol 2008, 29:374-376.
28. Reisner B.S., Shaw S., Huber M.E., et al. Comparison of three methods to recover vancomycin-resistant enterococci (VRE) from perianal and environmental samples collected during a hospital outbreak of VRE. Infect Control Hosp Epidemiol 2000, 21:775-779.